Driving Innovation to Tackle Global Health Challenges
Innovation is at the heart of
everything we do.
At CAM Bioceramics, innovation is at the heart of everything we do. Our team is dedicated to advancing cutting-edge solutions in partnership with leading research institutions, ensuring we remain at the forefront of medical advancements.
At CAM Bioceramics, we are proud to celebrate the accomplishments of our talented team and their dedication to advancing biomedical innovation. Congratulations to Robert Kamphof (PhD Student at CAM), Rui N.O. Lima (CAM intern), Dr. Giuseppe Cama (Head of R&D at CAM Bioceramics), and their co-authors on the publication of their groundbreaking research paper: "Antimicrobial Activity of Ion-Substituted Calcium Phosphates: A Systematic Review."
As a proud industry partner and work package leader in the NWO-funded DARTBAC Project, we are committed to driving innovation in antimicrobial technologies. This project focuses on developing and testing groundbreaking solutions to prevent and combat infections, addressing a critical need in modern healthcare.
Our collaboration with the DARTBAC Project underscores our unwavering commitment to research excellence and delivering impactful solutions to improve lives.
Research Paper: "Antimicrobial Activity of Ion-Substituted Calcium Phosphates: A Systematic Review."
Learn more about AMR
Tackling Antimicrobial Resistance (AMR)
Tackling Antimicrobial Resistance (AMR):
Infections surrounding bone implants remain a significant challenge in reconstructive surgery. As bacteria grow increasingly resistant to drugs, the shortage of effective antibiotics has become a pressing global health concern. Antimicrobial resistance (AMR) is one of the top 10 global health threats, often leading to implant revisions that cause patient discomfort and place a strain on healthcare systems worldwide.
Benefit of this research project
This research highlights the potential of ion-substituted calcium phosphates in addressing this critical issue. These materials offer antibacterial properties without relying on antibiotics, paving the way for the development of innovative implants for bone regeneration. Such advancements have the potential to significantly improve patient outcomes and reduce societal healthcare costs.
What is the DARTBAC project?
DARTBAC prepares the Netherlands for the post-antibiotic era caused by Anti Microbial Resistance (AMR)
Collectively, we possess the entire knowledge-chain for development of new material technologies to combat AMR.
Read more: https://nwa-dartbac.eu/
What are the DARTBAC project goals?
Within DARTBAC, new antimicrobial technologies are developed from a material perspective that do not assume antibiotics as the obvious means for infection prevention.
-
Stimulating social awareness around AMR
-
Developing new antimicrobial technologies
-
Optimizing AB efficacy through the use of combination therapy
-
Standardizing test models for accelerated clinical implementation